Nanoform completes share issue
24th March 2022
Submitted by:
Andrew Warmington
Helsinki-based nanoparticle medicine specialist Nanoform has completed a new share issue, in the process raising about €25 million from global and Nordic institutional investors. This will mainly be used to build a GMP manufacturing site in the US, where most of the company’s customers are.
The company said that it “continues to be committed to the strong execution of its communicated strategy”, having reached all its near-term targets for 2021 and being on track to deliver on its targets for 2022. The funding from an IPO it did in 2020 and the new share issue were said to be “sufficient for the growth strategy” it has outlined.